Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for <i>RAS</i> wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Authors

Eray Goekkurt (ORCID: https://orcid.org/0000-0003-1338-419X)
Stefan Kasper (ORCID: https://orcid.org/0000-0002-5947-8733)
Arndt Stahler (ORCID: https://orcid.org/0000-0003-1041-0137)
Armin Jarosch (ORCID: https://orcid.org/0000-0002-6040-394X)
Sebastian Stintzing (ORCID: https://orcid.org/0000-0002-3297-5801)
Volker Heinemann (ORCID: https://orcid.org/0000-0002-1349-3321)
Anke Reinacher‐Schick (ORCID: https://orcid.org/0000-0002-7838-6877)
Annika Kurreck (ORCID: https://orcid.org/0000-0002-4352-6788)
Alexej Ballhausen (ORCID: https://orcid.org/0000-0002-5470-4973)
Lars Bullinger (ORCID: https://orcid.org/0000-0002-5890-5510)
Dominik Paul Modest (ORCID: https://orcid.org/0000-0002-6853-0599)
Annabel Helga Sophie Alig (ORCID: https://orcid.org/0000-0002-3922-3450)
Ullrich Graeven (ORCID: https://orcid.org/0000-0001-6082-7710)
David Horst (ORCID: https://orcid.org/0000-0003-4755-5743)
Stefan Fruehauf (ORCID: https://orcid.org/0000-0002-4909-7427)
Lothar Müller (ORCID: https://orcid.org/0000-0001-9252-4650)
Ludwig Fischer von Weikersthal (ORCID: https://orcid.org/0000-0002-9128-0807)
Tanja Trarbach (ORCID: https://orcid.org/0009-0001-4804-9677)
Susanna Swoboda

Publication Details

Published: 2025-10-01
DOI: https://doi.org/10.1158/1078-0432.30255118
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for RAS wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Eray Goekkurt, Stefan Kasper, Arndt Stahler, Armin Jarosch, Sebastian Stintzing, Volker Heinemann, Anke Reinacher‐Schick, Annika Kurreck, Alexej Ballhausen, Lars Bullinger, Dominik Paul Modest, Annabel Helga Sophie Alig, Ullrich Graeven, David Horst, Stefan Fruehauf, Lothar Müller, Ludwig Fischer von Weikersthal, Tanja Trarbach, Susanna Swoboda

October 1, 2025article en

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for <i>RAS</i> wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Authors

Publication Details

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for RAS wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for RAS wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for &lt;i&gt;RAS&lt;/i&gt; wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Authors

Publication Details

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for RAS wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for RAS wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Supplementary Figure S2 from Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti–EGFR-Based Maintenance for <i>RAS</i> wt Metastatic CRC—The PanaMa (AIO KRK0212) Trial